United States securities and exchange commission logo June 23, 2022 Eric A. Adams President and Chief Executive Officer InMed Pharmaceuticals Inc. 815 W. Hastings Street, Suite 310 Vancouver, B.C. V6C 1B4 Canada Re: InMed Pharmaceuticals Inc. Registration Statement on Form S-1 Filed June 21, 2022 File No. 333-265731 Dear Mr. Adams: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brian Fenske, Esq.